LKT Labs

Biochemicals for Life Science Research

Boc-FAAGRK-AMC

Boc-FAAGRK-AMC

Product ID B5608
Cas No.
Purity ≥98%
Product Unit SizeCostQuantityStock
20 mg $1,308.20 Please Inquire
Bulk Quote

Quicklinks

Description

This peptide is a protease substrate that is used to measure protease activity in vitro.

Product Info

Purity

≥98%
Formula

C44H63N11O6
Formula Wt.

906.0
Solubility

Soluble in water.

Shipping and Storage

Store Temp

-20°C
Ship Temp

Ambient

Downloads

Info Sheet

B5608 Info Sheet PDF

References

Santoni M, Amantini C, Morelli MB, et al. Pazopanib and sunitinib trigger autophagic and non-autophagic death of bladder tumour cells. Br J Cancer. 2013 Aug 20;109(4):1040-50. PMID: 23887605.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • T1020

    n-Butyl Analog of Paclitaxel

    Fermentation impurity

    ≥95%
  • A706840

    ARV-825

    Degrades of BET proteins.

    ≥99%
  • C1867

    Ceramide

    Endogenous sphingosine-based lipid, component o...

    ≥98%
  • F8272

    Fusarenon X

    Trichothecene mycotoxin produced by Fusarium.

    ≥98%
  • C0824

    CCG1423

    Serum response factor inhibitor and MRTF-A bind...

    ≥98%
  • M0273

    Mastoparan 8

    Antimicrobial peptide found in bee and wasp ven...

    ≥95%
  • C0249

    Calcitonin Gene Related Peptide (8-37), rat

    Endogenous calcitonin-family peptide frgament, ...

    ≥95%
  • L8276

    Luteinizing Hormone Releasing Hormone

    Endogenous peptide hormone; GnRH agonist.

    ≥98%
  • L4796

    LY-294002

    PI3K inhibitor.

    ≥99%
  • P0246

    Palomid 529

    mTOR inhibitor.

    ≥98%
  • N3278

    7-Nitroindazole

    nNOS inhibitor.

    ≥98%
  • D1769

    Dermorphin

    Opioid peptide; μOR agonist.

    ≥96%
  • T2792

    TGX-221

    p110β PI3K inhibitor.
  • T5720

    Tofacitinib Citrate

    JAK1/2/3 inhibitor.

    ≥99%
  • R2714

    Recombinant HCV-NS5 Antigens

    Recombinant HCV antigen fragment.

    ≥95%
  • D1720

    Deferiprone

    Iron chelator.

    ≥99%
  • D5792

    Doxofylline

    Xanthine derivative; PDE inhibitor.

    ≥98%
  • C9662

    Cyproterone Acetate

    Steroid; AR antagonist.

    ≥98%
  • T1006

    10-Acetoacetyl Paclitaxel

    Synthesis impurity

    ≥95%
  • O783743

    OTSSP167 Hydrochloride

    MELK inhibitor.

    ≥98%